# MENS catalysts: Jyong Biotech Ltd. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/mens/catalysts

> Jyong Biotech Ltd. (MENS) has no upcoming catalysts in this calendar. The latest recorded is the Jyong Biotech Ltd. NDA/BLA acceptance, December 17, 2022.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA catalysts for MENS?

Jyong Biotech Ltd. (MENS) has no upcoming catalysts in this calendar. The latest recorded is the Jyong Biotech Ltd. NDA/BLA acceptance, December 17, 2022. SEC prospectus (424B): "We resubmitted an NDA for MCS-2 using API-1 to the US FDA on December 17, 2022, the US FDA accepted our NDA for review "with issues identified."" [Calendar and source filings](https://sec-api.dev/companies/mens/catalysts)

Source: SEC prospectus (424B), accession 0001213900-25-055414, https://www.sec.gov/Archives/edgar/data/1954488/000121390025055414/ea0200696-25.htm (retrieved 2026-11-12). Last confirmed 2025-06-18. Cite: https://sec-api.dev/companies/mens/catalysts#answer

## Company

| Field | Value |
| --- | --- |
| Name | Jyong Biotech Ltd. |
| Ticker | MENS (Nasdaq) |
| SEC CIK | 1954488 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/mens |

## Cash runway

Cash $1.2M as of 2025-12-31; quarterly burn $761K; about 4.6 months of runway at that rate (XBRL company facts, accession 0001213900-26-057073).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| February 22, 2022 | [Jyong Biotech Ltd. NDA/BLA acceptance](https://sec-api.dev/companies/mens/catalysts) | MENS |  | completed | "On February 22, 2022, the U.S. FDA accepted our NDA for review "with issues identified."" ([SEC prospectus (424B)](https://www.sec.gov/Archives/edgar/data/1954488/000121390025055414/ea0200696-25.htm)) |
| December 17, 2022 | [Jyong Biotech Ltd. NDA/BLA acceptance](https://sec-api.dev/companies/mens/catalysts) | MENS |  | completed | "We resubmitted an NDA for MCS-2 using API-1 to the US FDA on December 17, 2022, the US FDA accepted our NDA for review "with issues identified."" ([SEC prospectus (424B)](https://www.sec.gov/Archives/edgar/data/1954488/000121390025055414/ea0200696-25.htm)) |

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/mens/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "MENS catalysts: Jyong Biotech Ltd. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/mens/catalysts

```bibtex
@misc{secapidev_companies_mens_catalysts_20261116,
  title        = {MENS catalysts: Jyong Biotech Ltd. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/mens/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_mens_catalysts_20261116","title":"MENS catalysts: Jyong Biotech Ltd. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/mens/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
